HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge.

Abstract
The currently available human vaccine for anthrax, derived from the culture supernatant of Bacillus anthracis, contains the protective antigen (PA) and traces of the lethal and edema factors, which may contribute to adverse side effects associated with this vaccine. Therefore, an effective expression system that can provide a clean, safe, and efficacious vaccine is required. In an effort to produce anthrax vaccine in large quantities and free of extraneous bacterial contaminants, PA was expressed in transgenic tobacco chloroplasts by inserting the pagA gene into the chloroplast genome. Chloroplast integration of the pagA gene was confirmed by PCR and Southern analysis. Mature leaves grown under continuous illumination contained PA as up to 14.2% of the total soluble protein. Cytotoxicity measurements in macrophage lysis assays showed that chloroplast-derived PA was equal in potency to PA produced in B. anthracis. Subcutaneous immunization of mice with partially purified chloroplast-derived or B. anthracis-derived PA with adjuvant yielded immunoglobulin G titers up to 1:320,000, and both groups of mice survived (100%) challenge with lethal doses of toxin. An average yield of about 150 mg of PA per plant should produce 360 million doses of a purified vaccine free of bacterial toxins edema factor and lethal factor from 1 acre of land. Such high expression levels without using fermenters and the immunoprotection offered by the chloroplast-derived PA should facilitate development of a cleaner and safer anthrax vaccine at a lower production cost. These results demonstrate the immunogenic and immunoprotective properties of plant-derived anthrax vaccine antigen.
AuthorsVijay Koya, Mahtab Moayeri, Stephen H Leppla, Henry Daniell
JournalInfection and immunity (Infect Immun) Vol. 73 Issue 12 Pg. 8266-74 (Dec 2005) ISSN: 0019-9567 [Print] United States
PMID16299323 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Anthrax Vaccines
  • Antigens, Bacterial
  • Bacterial Toxins
  • Immune Sera
  • Immunoglobulin G
  • anthrax toxin
Topics
  • Animals
  • Anthrax (prevention & control)
  • Anthrax Vaccines (administration & dosage, genetics, immunology)
  • Antigens, Bacterial (biosynthesis, genetics, immunology)
  • Bacterial Toxins (biosynthesis, genetics, immunology)
  • Blotting, Southern
  • Chloroplasts (genetics, metabolism)
  • Immune Sera (immunology)
  • Immunization
  • Immunoblotting
  • Immunoglobulin G (blood)
  • Macrophages (drug effects)
  • Mice
  • Mice, Inbred BALB C
  • Plant Leaves (genetics, metabolism)
  • Plants, Genetically Modified (genetics, metabolism)
  • Tobacco (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: